IRTC
iRhythm Holdings, Inc.
Key Financials
Net Income
$-44551000
↑ 60.7%
Gross Profit
$527.3M
↑ 29.4%
Operating Income
$-57407000
↑ 50.3%
Revenue
$747.1M
↑ 26.2%
EPS (Diluted)
$-1.39
↑ 61.7%
Shareholders' Equity
$152.7M
↑ 68.0%
Cash & Equivalents
$236.0M
↓ 43.8%
Total Liabilities
$867.3M
↑ 3.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IRTC |
| Company Name | iRhythm Holdings, Inc. |
| CIK | 1388658 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 415-632-5700 |